S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)

Chemed (CHE) Stock Forecast, Price & News

$519.70
-2.30 (-0.44%)
(As of 04:00 PM ET)
Compare
Today's Range
$514.25
$522.39
50-Day Range
$499.76
$568.61
52-Week Range
$430.16
$574.66
Volume
129,115 shs
Average Volume
70,810 shs
Market Capitalization
$7.84 billion
P/E Ratio
34.65
Dividend Yield
0.31%
Price Target
$593.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
15.0% Upside
$593.00 Price Target
Short Interest
Healthy
3.02% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
1.64mentions of Chemed in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$2.07 M Sold Last Quarter
Proj. Earnings Growth
16.74%
From $19.12 to $22.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.16 out of 5 stars

Medical Sector

16th out of 972 stocks

Home Health Care Services Industry

1st out of 7 stocks


CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CHE Price History

CHE Stock News Headlines

Chemed (CHE) Faces Macroeconomic Woes, Tough Competition
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Chemed - Showcasing Why It's So Reliable
Chemed (CHE) Declares $0.40 Dividend
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Chemed Corp. Raises Quarterly Dividend by 5.3% >CHE
Chemed: Q2 Earnings Snapshot
Chemed Corp. Q2 Income Retreats, misses estimates
Chemed (CHE) Q2 Earnings and Revenues Lag Estimates
Chemed Reports Second-Quarter 2023 Results
Here's what Wall Street expects from Chemed's earnings report
See More Headlines
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Company Calendar

Last Earnings
7/26/2023
Ex-Dividend for 9/5 Dividend
8/11/2023
Dividend Payable
9/05/2023
Today
9/29/2023
Next Earnings (Estimated)
10/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,167
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$593.00
High Stock Price Forecast
$610.00
Low Stock Price Forecast
$576.00
Forecasted Upside/Downside
+15.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$249.62 million
Pretax Margin
13.73%

Debt

Sales & Book Value

Annual Sales
$2.13 billion
Cash Flow
$24.12 per share
Book Value
$53.71 per share

Miscellaneous

Free Float
14,469,000
Market Cap
$7.77 billion
Optionable
Optionable
Beta
0.53

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Kevin J. McNamaraMr. Kevin J. McNamara (Age 69)
    CEO, Pres & Director
    Comp: $5.66M
  • Mr. David P. Williams (Age 62)
    Exec. VP & CFO
    Comp: $2.63M
  • Mr. Michael D. Witzeman CPA (Age 52)
    MBA, VP & Controller
    Comp: $985.01k
  • Mr. Spencer S. LeeMr. Spencer S. Lee (Age 67)
    Exec. VP
    Comp: $1.86M
  • Mr. Thomas C. Hutton (Age 72)
    VP & Director
  • Mr. Nicholas Michael WestfallMr. Nicholas Michael Westfall (Age 44)
    Exec. VP
    Comp: $2.05M
  • Ms. Lisa A. Reinhard
    VP, Chief Admin. Officer & Sec.
  • Sherri Warner
    Director of Investor Relations
  • Mr. Brian C. Judkins (Age 42)
    VP, Sec. & Chief Legal Officer













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2023?

1 Wall Street analysts have issued 12 month price objectives for Chemed's stock. Their CHE share price forecasts range from $576.00 to $610.00. On average, they anticipate the company's share price to reach $593.00 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2023?

Chemed's stock was trading at $510.43 at the start of the year. Since then, CHE shares have increased by 1.0% and is now trading at $515.58.
View the best growth stocks for 2023 here
.

Are investors shorting Chemed?

Chemed saw a decrease in short interest in September. As of September 15th, there was short interest totaling 443,600 shares, a decrease of 13.3% from the August 31st total of 511,700 shares. Based on an average daily trading volume, of 71,500 shares, the days-to-cover ratio is currently 6.2 days. Currently, 3.0% of the shares of the company are short sold.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) released its earnings results on Wednesday, July, 26th. The company reported $4.71 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.09 by $0.38. The company had revenue of $553.80 million for the quarter, compared to analysts' expectations of $562.54 million. Chemed had a net margin of 10.36% and a trailing twelve-month return on equity of 34.65%. The company's revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business earned $4.84 EPS.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, August 4th. Shareholders of record on Monday, August 14th will be given a dividend of $0.40 per share on Tuesday, September 5th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Friday, August 11th. This is an increase from the stock's previous quarterly dividend of $0.38.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.31%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 10.67%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.17% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY 2023 earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $19.90-$20.10 for the period, compared to the consensus EPS estimate of $20.92. The company issued revenue guidance of -.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $515.58.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $7.77 billion and generates $2.13 billion in revenue each year. The company earns $249.62 million in net income (profit) each year or $15.00 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,167 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -